SV2003001085A - Compuesto farmaceutico - Google Patents
Compuesto farmaceuticoInfo
- Publication number
- SV2003001085A SV2003001085A SV2002001085A SV2002001085A SV2003001085A SV 2003001085 A SV2003001085 A SV 2003001085A SV 2002001085 A SV2002001085 A SV 2002001085A SV 2002001085 A SV2002001085 A SV 2002001085A SV 2003001085 A SV2003001085 A SV 2003001085A
- Authority
- SV
- El Salvador
- Prior art keywords
- pharmaceutical compound
- methylipiperidin
- phenylglycinyl
- carbonil
- difumarate
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 108010074860 Factor Xa Proteins 0.000 abstract 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical group C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 abstract 1
- 108010022999 Serine Proteases Proteins 0.000 abstract 1
- 102000012479 Serine Proteases Human genes 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
EL DIFUMARATO DE 1-(INDOL-6-CARBONIL-D-FENILGLICINIL)-4-(1-METILPIPERIDIN-4-IL) PIPERAZINA FORMA UNA SAL CRISTALINA ESTABLE Y ES UN INHIBIDOR DE LA PROTEASA DE SERINA, FACTOR XA, UTIL EN EL TRATAMIENTO DE TRASTORNOS CARDIOVASCULARES
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2001/002553 WO2001096323A1 (en) | 2000-06-13 | 2001-06-12 | Serine protease inhibitors |
| US33929501P | 2001-12-12 | 2001-12-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV2003001085A true SV2003001085A (es) | 2003-03-18 |
Family
ID=41210812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2002001085A SV2003001085A (es) | 2001-06-12 | 2002-06-11 | Compuesto farmaceutico |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20040162295A1 (es) |
| EP (1) | EP1397348B1 (es) |
| JP (1) | JP2004534062A (es) |
| AR (1) | AR036048A1 (es) |
| AT (1) | ATE305452T1 (es) |
| AU (1) | AU2002348501A1 (es) |
| DE (1) | DE60206376T2 (es) |
| ES (1) | ES2248618T3 (es) |
| MY (1) | MY137876A (es) |
| PE (1) | PE20030198A1 (es) |
| SV (1) | SV2003001085A (es) |
| TW (1) | TWI257389B (es) |
| WO (1) | WO2002100847A2 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002322396A1 (en) * | 2001-07-26 | 2003-02-17 | Eli Lilly And Company | 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists |
| MXPA04009640A (es) | 2002-04-01 | 2005-01-11 | Lilly Co Eli | Determinados compuestos de 1-(d-ciclopropilglicinil)-4-(pieridin-4-il)piperazina como inhibidores del factor xa de serina proteasa. |
| KR100849242B1 (ko) * | 2004-06-30 | 2008-07-29 | 일라이 릴리 앤드 캄파니 | 1(인돌-6-카르보닐-ｄ-페닐글리시닐)-4-(1-메틸피페리딘-4-일) 피페라진 ｄ-타르트레이트 |
| CN1984903A (zh) * | 2004-06-30 | 2007-06-20 | 伊莱利利公司 | 1－(吲哚－6－羰基－d－苯基甘氨酰基)－4－(1－甲基哌啶－4－基)哌嗪d－酒石酸盐 |
| DE102007028406A1 (de) | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituierte Oxazolidinone und ihre Verwendung |
| DE102007028407A1 (de) | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituierte Oxazolidinone und ihre Verwendung |
| DE102007028319A1 (de) | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituierte Oxazolidinone und ihre Verwendung |
| JP2015524400A (ja) * | 2012-07-19 | 2015-08-24 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ９−［４−（３−クロロ−２−フルオロ−フェニルアミノ）−７−メトキシ−キナゾリン−６−イルオキシ］−１，４−ジアザ−スピロ［５．５］ウンデカン−５−オンのフマル酸塩、その薬物としての使用及び調製 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6855715B1 (en) * | 1999-06-14 | 2005-02-15 | Eli Lilly And Company | Serine protease inhibitors |
| GB0030304D0 (en) * | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
-
2002
- 2002-06-05 TW TW091112134A patent/TWI257389B/zh not_active IP Right Cessation
- 2002-06-06 JP JP2003503615A patent/JP2004534062A/ja active Pending
- 2002-06-06 US US10/477,192 patent/US20040162295A1/en not_active Abandoned
- 2002-06-06 WO PCT/US2002/016569 patent/WO2002100847A2/en not_active Ceased
- 2002-06-06 DE DE60206376T patent/DE60206376T2/de not_active Expired - Fee Related
- 2002-06-06 ES ES02778933T patent/ES2248618T3/es not_active Expired - Lifetime
- 2002-06-06 AU AU2002348501A patent/AU2002348501A1/en not_active Abandoned
- 2002-06-06 EP EP02778933A patent/EP1397348B1/en not_active Expired - Lifetime
- 2002-06-06 AT AT02778933T patent/ATE305452T1/de not_active IP Right Cessation
- 2002-06-10 MY MYPI20022155A patent/MY137876A/en unknown
- 2002-06-10 PE PE2002000496A patent/PE20030198A1/es not_active Application Discontinuation
- 2002-06-11 AR ARP020102199A patent/AR036048A1/es unknown
- 2002-06-11 SV SV2002001085A patent/SV2003001085A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MY137876A (en) | 2009-03-31 |
| WO2002100847A3 (en) | 2003-08-21 |
| EP1397348B1 (en) | 2005-09-28 |
| DE60206376D1 (de) | 2006-02-09 |
| PE20030198A1 (es) | 2003-03-12 |
| US20040162295A1 (en) | 2004-08-19 |
| AU2002348501A1 (en) | 2002-12-23 |
| TWI257389B (en) | 2006-07-01 |
| JP2004534062A (ja) | 2004-11-11 |
| ATE305452T1 (de) | 2005-10-15 |
| DE60206376T2 (de) | 2006-06-22 |
| AR036048A1 (es) | 2004-08-04 |
| ES2248618T3 (es) | 2006-03-16 |
| WO2002100847A2 (en) | 2002-12-19 |
| EP1397348A2 (en) | 2004-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY136883A (en) | 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition | |
| JO2646B1 (en) | New differentiated cyclic compounds as beta - lactam inhibitors | |
| GEP20074098B (en) | Lactam-containing compounds and derivatives thereof as factor xa inhibitors | |
| NO20045065L (no) | Nytt formatsalt av o-desmetyl-venlafaxin | |
| CY2008008I1 (el) | Ν-υποκατεστημενοι υδροξυπυριμιδινονο-καρβοξαμιδικοι ανσατολεις της ιντεγρασης hiv | |
| ATE374765T1 (de) | Substituierte heterocyclische amide | |
| UA94390C2 (ru) | Применение производных индолинонов, предназначенных для лечения или предупреждения идиопатического фиброза легких | |
| DE60105419D1 (de) | Serinprotease-inhibitoren | |
| IS6069A (is) | N-cýanómetýlamíð sem próteasalatar | |
| DE60135087D1 (de) | Dipeptidnitrile als inhibitoren von cathepsin k | |
| DE60105418D1 (de) | Serinprotease-inhibitoren | |
| SV2003001085A (es) | Compuesto farmaceutico | |
| NO20023956D0 (no) | Priperidin- og piperazinsubstituerte N-hydroksyformamider som inhibitorer av metalloproteinaser | |
| DE60033809D1 (de) | Inhibitoren von metalloproteinasen | |
| ATE287416T1 (de) | Thrombin inhibitoren | |
| EA200700186A1 (ru) | Фармацевтическое соединение | |
| ATE303990T1 (de) | Bestimmte 1-(d-cyclopropylglycinyl)-4-(piperidin- 4-yl)piperazin verbindungen als inhibitoren der serin protease factor xa | |
| NO20031698D0 (no) | Krystallformer av 1-(6-klor-5-(trifluormetyl)-2- pyridinyl)piperazin-hydroklorid | |
| SI1492767T1 (sl) | Dolocene 1-(d-ciklopropilglicinil)-4-(piperidin-4-il)piperazinske spojine kot inhibitorji faktorja xa serinske proteaze | |
| TH64469A (th) | สารประกอบทางเภสัชกรรม | |
| UY26973A1 (es) | Derivados puente de piperazina | |
| NO20042160L (no) | Inhibitorer av 11-betahydroksysteroid dehydrogenase type 1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Lapse |